Menu
If you are seeing this, please disable your adblock software to view the full version of our annual report!
Sustaining Connections in CGT
2022 ISCT Annual report
Sustaining Connections in CGT
2022 ISCT Annual report
Jacques Galipeau, MD
President
June 20202- June 2024
University of Wisconsin-Madison
United States
Connecting the Global ISCT Community
This year ISCT has put every effort into reconnecting with the wider CGT community post-pandemic on both a global and regional level. Our leaders, with support from head office have worked tirelessly to address key issues facing the CGT sector to drive translation, create new international partnerships and expand the global reach of our society, particularly by opening doors for newcomers.
Queenie Jang, BSc (Pharmacy), MBA,
Chief Executive Officer
Canada
Investing in the Workforce of the Future
Over the last year, ISCT has focused its investments on building a home for workforce development within the DNA of ISCT. Working with our expansive network of global key opinion leaders and subject matter experts, we have made significant investments to expand our educational offerings. From online resources to practical in-person programs, ISCT members now have access to a wide array of supports.
Our Board of Directors
The ISCT Board of Directors consists of:
- President (Chair of the Board of Directors)
- President-Elect
- Immediate Past President (Chair of the Strategic Advisory Council)
- Global Secretary
- Global Treasurer
- Regional Vice Presidents
- Chief Scientific Officer
- Chief Regulatory Officer
- Chief Commercialization Officer
- 4 Elected ISCT Members
- Senior Editor of the Society’s Journal
- Chief Executive Officer
The Board of Directors is the main administrative body which manages the governance and strategic oversight of the Society.
Our Three Pillars
Since 1992, ISCT has worked to advance cell and gene therapies through a focus on translational value,
bridging experts across scientific, regulatory, and commercial fields to drive consensus and action at a global level.
Membership: 47% outside of the United States from 60+ countries
Re-Connecting the Global Cell and Gene Community in San Francisco
Since 1992, ISCT has connected more than 22,000 delegates through our Annual Meetings and communicated with more than 38,000 cell and gene therapy professionals at cutting-edge meetings, events, webinars and seminars to translate the advancement of research into clinical adoption and standard of care over the past 30 years.
ISCT 2022 San Francisco was a stand-out event for ISCT as the Society was excited to welcome delegates to the first in-person ISCT meeting Post Pandemic while also celebrating 30 years of ISCT supporting the work of cell and gene professionals worldwide. To mark the significance of this year, ISCT worked diligently to ensure that ISCT 2022 delivered the most innovative and comprehensive program yet.
With the guidance and leadership of the meeting co-chairs and organizing committee, ISCT 2022 introduced the Translational Pathway Program, structured to mirror therapeutic development and integrated a variety of perspectives to address key topics at all stages of translation. In parallel, leadership also introduced a brand-new roundtable session program. Over 30 roundtable sessions were hosted, providing more practical and engaging discussions covering the full range of therapies from Bench to Bedside to Benefit.
Meeting Co-Chairs:
Sandeep Soni
MD
MD
CRISPR Therapeutics, Inc.
University of California, San Francisco
University of California, San Francisco
Bambi Grilley, RPh, RAC,
CIP, CCRC, CCRP
Baylor College of Medicine
Sven Kili
MBChB, MRCS (Eng)
MBChB, MRCS (Eng)
Antion Biosciences SA
In 2022, ISCT granted the ISCT Career Achievement Award and the Darwin J. Prockop Mentoring Award to commemorate the contributions of two inspiring ISCT community leaders. These awards, honour outstanding individuals who have made signification contributions to the field of cell and gene therapy and excelled as inspiring mentors.
This year, Robert A. Preti, PhD received the ISCT Career Achievement Award, the highest honour from ISCT, for his long and distinguished service to advancing the overall cell and gene therapy field, resulting in significant achievements that benefit patients.
Patricia Rocco, MD, Ph.D. received the 2022 Darwin J. Prockop Mentoring Award for her outstanding mentorship, dedicating her career to inspire, guide and cultivate their mentee’s ongoing development in the field of cell and gene therapy.
Membership to Meet Your Needs
ISCT members are the core of our Society. With member representation at every step of the translational pathway, ISCT serves to support your unique needs as we advance the CGT field together. ISCT offers tailored membership categories for Individuals, Labs, and Industry Companies – Find the membership best suited for you.
- Reduced rates at ISCT-sponsored events, including webinars, technical workshops, research and clinical symposia, and the ISCT meetings.
- Access to members-only web resources, including the ISCT Member Networking Database and online discussion boards.
Meetings – Save The Date
“Celebrating the Progress of Advanced Therapies and Building the Future Through Translation”
We can’t wait to see you in Paris!
Join us in Paris for the largest and most anticipated Annual Meeting yet where you will revitalize past networks and spark new connections. Brining back our roundtable sessions and Translational Pathway Program for the second year running, ISCT 2023 will deliver the most comprehensive educational program bridging together innovative translation, therapeutic design, clinical evaluation, and commercial adoption of cell and gene therapies.
ISCT Career Center
Recruiting, or looking to be recruited?
With access to the most expansive network of Cell and Gene therapy professionals, our job postings engage and help laboratories worldwide to expand as they seek qualified technicians, scientists, and business professionals. If you manage or are part of a lab, please inquire about our efforts to support your growth through catered job postings and outreach. Visit the ISCT Career Center to view the most current and sought after jobs on the market worldwide
Join the Conversation
The ISCT website is home to several engaged discussion boards where you can connect with like-minded professionals. Through our interactive website, networking within the Society is easier than ever. All members are invited to participate in the ISCT community discussions, and membership is open to interested CGT stakeholders.
VISIT THE WEBSITE
Our Volunteer Center
The ISCT Volunteer Center is the new hub designed to facilitate members seeking to join one of our 43 standing committees, or to contribute to our monthly e-newsletter, Telegraft.
If you have a passion for the advancement of the field of cell and gene therapy, and you wish to contribute your voice towards shaping the field by sharing your expertise and experience, please check in regularly to the volunteer center, as opportunities are expected to expand.
Our Committees
ISCT has 43 stakeholder committees, working in a number of scientific, commercial and regulatory disciplines within cell and gene therapy. Joining an ISCT committee is an invaluable networking opportunity, allowing you to connect with cell and gene therapy professionals from all over the world. If you would like to bolster your career by joining an ISCT committee, visit our Committees page to see how.
Showcase Your Research:
Cytotherapy
Cytotherapy, official journal of the International Society for Cell & Gene Therapy (ISCT®), publishes novel and innovative results from high quality basic, translational and clinical studies in the fields of cell and gene therapy.
Aims and Scope:
Studies evaluating the potency of experimental cell and gene therapies in clinically relevant animal models of disease and describing important advances in cell/gene-based product manufacturing and validation are welcomed. Results of clinical studies evaluating the safety and efficacy of cell and gene therapies in early and late phase trials are also of interest. In addition to Short Reports and Full-Length Articles, the journal also accepts Editorials addressing emerging trends and potential controversies in the field, and Review articles summarizing bodies of work that have made lasting impacts in the field.
Interested in showcasing your research with Cytotherapy?
Please get in touch with Dr. Patrick Hanley, Commissioning Editor
Telegraft:
Available to ISCT members around the world, Telegraft is the Society’s leading global cell therapy newsletter which updates readers on new cell and gene therapy developments, regulatory updates, and regular columns on related meetings, organizations, and events, summaries of work being done in both academic and industry labs around the world.
With the introduction of the new Telegraft Hub website, it is easier than ever to reach and engage with the global ISCT community. If you are interested in contributing an article to Telegraft, or in helping out with our editorial process, please visit here.
Global Training Programs
Through strategic partnerships with key organizations and centers of excellence, ISCT launched a number of accredited training programs in 2022.
These programs include, Workforce Development in Bio Manufacturing, The Cell Therapy Training Course, and The Masters in Manufacturing of Advanced Therapy Medicine Products (ATMPs) Scholarship Programme. ISCT also has a number of additional recurring programs and workshop available free of charge to ISCT members such as The ISCT ESP Programs and The Educational Program on Advanced Therapy Manufacturing.
For more information on upcoming programs and how to register visit The ISCT Training Program Resource Library.
Tools for Learning
ISCT has a large number of valuable and comprehensive resources for ISCT members and cell and gene therapy professionals.
Resources include key reports, presentations, and publications across ISCT programs, including annual meeting presentations, webinars, and online course programs developed in partnership with the Andalusian Network for the Design & Translation of Advanced Therapies. ISCT also makes available valuable patient resources from the innovative ISCT Presidential Task Force (PTF) on the Use of Unproven and/or Unethical Cell and Gene Therapies website, which was launched in 2018.
Visit the Resource Library to learn more.
ISCT 2022 Annual report
If you are seeing this, please disable your adblock software to view the full version of our annual report!
